Koon K Teo Selected Research

Phospholipids (Phosphatides)

1/2017	Autoantibodies and immune complexes to oxidation-specific epitopes and progression of aortic stenosis: Results from the ASTRONOMER trial.
9/2015	Oxidized Phospholipids, Lipoprotein(a), and Progression of Calcific Aortic Valve Stenosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Koon K Teo Research Topics

Disease

27	Cardiovascular Diseases (Cardiovascular Disease) 10/2023 - 09/2005
25	Myocardial Infarction 10/2023 - 01/2002
21	Coronary Artery Disease (Coronary Atherosclerosis) 03/2023 - 04/2003
19	Heart Failure 10/2023 - 07/2002
18	Stroke (Strokes) 10/2023 - 10/2002
13	Aortic Valve Stenosis (Aortic Stenosis) 03/2023 - 06/2008
12	Coronary Disease (Coronary Heart Disease) 03/2016 - 01/2002
11	Hypertension (High Blood Pressure) 01/2023 - 01/2002
10	Myocardial Ischemia (Ischemic Heart Diseases) 01/2019 - 06/2006
9	Vascular Diseases (Vascular Disease) 01/2021 - 09/2004
8	Albuminuria 07/2016 - 07/2009
6	Chronic Renal Insufficiency 07/2016 - 12/2009
5	Diabetes Mellitus 01/2019 - 01/2002
4	Insulin Resistance 10/2023 - 04/2010
4	Obesity 06/2023 - 04/2007
4	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 08/2015
4	Hypotension (Low Blood Pressure) 01/2019 - 09/2009
4	Acute Coronary Syndrome 09/2017 - 01/2002
4	Atherosclerosis 01/2017 - 02/2006
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2013 - 04/2010
3	Neoplasms (Cancer) 01/2021 - 10/2004
3	Death (Near-Death Experience) 01/2020 - 09/2004
3	Ischemia 01/2019 - 03/2008
3	Atrial Fibrillation 09/2017 - 03/2003
3	Type 2 Diabetes Mellitus (MODY) 07/2016 - 10/2013
3	Angioedema 09/2013 - 04/2008
3	Stable Angina 09/2013 - 08/2008
3	Left Ventricular Dysfunction 01/2005 - 10/2002
2	Pediatric Obesity 06/2023 - 01/2023
2	Glucose Intolerance 01/2022 - 02/2003
2	Birth Weight (Birth Weights) 11/2017 - 08/2017
2	Hyperkalemia 12/2014 - 02/2013
2	Proteinuria 10/2014 - 08/2008
2	Diabetic Nephropathies (Diabetic Nephropathy) 02/2013 - 07/2009
2	Pathologic Constriction (Stenosis) 07/2012 - 12/2011
2	Cough 06/2011 - 04/2008
1	Inflammation (Inflammations) 03/2023

Drug/Important Bio-Agent (IBA)

22	Ramipril (Altace)FDA LinkGeneric 01/2021 - 09/2004
21	Telmisartan (Micardis)FDA Link 01/2021 - 04/2008
19	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 10/2002
11	CreatinineIBA 01/2022 - 07/2009
11	Angiotensin Receptor AntagonistsIBA 01/2021 - 04/2008
9	Glucose (Dextrose)FDA LinkGeneric 10/2023 - 02/2003
9	Rosuvastatin Calcium (Crestor)FDA Link 01/2017 - 06/2008
7	LipidsIBA 01/2020 - 02/2006
7	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 09/2013 - 10/2002
6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2015 - 01/2002
5	HDL CholesterolIBA 01/2020 - 07/2011
5	CholesterolIBA 01/2018 - 01/2002
4	Lipoprotein(a)IBA 03/2023 - 09/2015
4	SodiumIBA 01/2020 - 10/2013
3	Triglycerides (Triacylglycerol)IBA 10/2023 - 01/2013
3	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 11/2012
3	AlbuminsIBA 01/2021 - 02/2013
3	1-penicillamyl-Leu(2)- oxytocinIBA 01/2020 - 09/2015
3	Apolipoproteins B (ApoB)IBA 01/2020 - 09/2015
3	lipoprotein cholesterolIBA 01/2019 - 09/2009
3	Indicators and Reagents (Reagents)IBA 11/2017 - 12/2002
3	Valsartan (Vals)FDA Link 06/2009 - 01/2005
3	candesartanIBA 06/2009 - 01/2005
2	oxidized low density lipoproteinIBA 10/2023 - 01/2017
2	LDL Lipoproteins (beta Lipoproteins)IBA 10/2023 - 01/2017
2	Glutamic Acid (Glutamate)FDA Link 06/2023 - 01/2023
2	Biomarkers (Surrogate Marker)IBA 06/2023 - 03/2023
2	Threonine (L-Threonine)FDA Link 06/2023 - 01/2023
2	VaccinesIBA 02/2022 - 07/2012
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2022 - 01/2019
2	Digoxin (Digitek)FDA LinkGeneric 01/2019 - 12/2003
2	FatsIBA 11/2017 - 01/2008
2	CarbohydratesIBA 11/2017 - 04/2010
2	Insulin (Novolin)FDA Link 08/2017 - 01/2013
2	Immunoglobulin G (IgG)IBA 01/2017 - 12/2002
2	Phospholipids (Phosphatides)FDA LinkGeneric 01/2017 - 09/2015
2	ApolipoproteinsIBA 01/2017 - 01/2009
2	PotassiumIBA 12/2014 - 07/2012
2	Proteins (Proteins, Gene)FDA Link 09/2014 - 10/2013
2	Simvastatin (Zocor)FDA LinkGeneric 10/2013 - 04/2003
2	EnzymesIBA 09/2013 - 02/2013
2	Clopidogrel (Plavix)FDA Link 11/2012 - 12/2009
2	LDL CholesterolIBA 04/2010 - 01/2002
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2009 - 10/2002
2	Warfarin (Coumadin)FDA LinkGeneric 12/2009 - 03/2003
2	Captopril (Capoten)FDA LinkGeneric 07/2008 - 01/2005
1	gamma-Aminobutyric Acid (GABA)IBA 06/2023
1	Carnitine (L-Carnitine)FDA LinkGeneric 06/2023
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 06/2023
1	Aminobutyrates (Aminobutyric Acid)IBA 06/2023
1	Acetylcarnitine (Alcar)IBA 06/2023
1	symmetric dimethylarginineIBA 06/2023
1	C-Reactive ProteinIBA 03/2023
1	Leucine (L-Leucine)FDA Link 01/2023
1	Glutamine (L-Glutamine)FDA Link 01/2023
1	Aromatic Amino Acids (Aromatic Amino Acid)IBA 01/2023

Therapy/Procedure

45	Therapeutics 01/2019 - 01/2002
23	Percutaneous Coronary Intervention 01/2019 - 06/2006
6	Secondary Prevention 11/2020 - 07/2008
2	Plant-Based Diet 01/2020 - 11/2017
2	Drug Therapy (Chemotherapy) 10/2015 - 12/2012
2	Stents 01/2007 - 06/2006
1	Denervation 01/2023